BMY vs EVRG · P/E 17, rev $24.46B vs P/E 22, rev $5.96B
Bristol-Myers Squibb Company (BMY) versus Evergy, Inc. (EVRG) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Evergy, Inc. (EVRG) is a utilities - regulated electric company listed on NASDAQ.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported EVRG revenue for 2025-12-31 was $5.96B. Net income was $855.6M. Revenue was up 2.0% from 2024-12-31 to 2025-12-31. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. EVRG currently screens at market cap $19.10B and trailing P/E 22.0.
Not investment advice. Open the BMY and EVRG stock pages for the full models.
Not investment advice.